BNP Paribas Financial Markets
MBX

BNP Paribas Financial Markets’s MBX Biosciences MBX Stock Holding History

BNP Paribas Financial Markets’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
10,384
+3,600
+53% +$122K ﹤0.01% 3842
2025
Q4 		$214K Buy
6,784
+3,888
+134% +$94.3K ﹤0.01% 4028
2025
Q3 		$50.7K Buy
2,896
+1,567
+118% +$21K ﹤0.01% 4599
2025
Q2 		$15.2K Sell
1,329
-29,587
-96% -$301K ﹤0.01% 4716
2025
Q1 		$228K Buy
30,916
+29,430
+1,980% +$311K ﹤0.01% 3623
2024
Q4 		$27.4K Buy
+1,486
New +$31.7K ﹤0.01% 4638

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BNP Paribas Financial Markets's MBX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its MBX Biosciences (MBX) stake by 53% in Q1 2026, buying an estimated $122K and bringing the position to 10,384 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

BNP Paribas Financial Markets first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • BNP Paribas Financial Markets held 10,384 shares of MBX Biosciences worth $310K as of Q1 2026.
  • BNP Paribas Financial Markets bought 3,600 MBX Biosciences shares in Q1 2026, an estimated $122K.
  • MBX Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3842 holding.
  • BNP Paribas Financial Markets first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.